In addition, decitabine has been shown to improve the sensitivity of anti-PD1/PDL1 in AML by regulating DNA methylation, in which DNMT1 could be a crucial regulator [100,101]. This evidence concerns the gene DNMT1 and acute myeloid leukemia.